高级搜索

放射治疗配合全身化疗治疗局部晚期鼻咽癌

宋启斌, 胡德胜, 周晓艺, 曾凡玉, 魏来, 皮正超

宋启斌, 胡德胜, 周晓艺, 曾凡玉, 魏来, 皮正超. 放射治疗配合全身化疗治疗局部晚期鼻咽癌[J]. 肿瘤防治研究, 2002, 29(04): 339-340. DOI: 10.3971/j.issn.1000-8578.3313
引用本文: 宋启斌, 胡德胜, 周晓艺, 曾凡玉, 魏来, 皮正超. 放射治疗配合全身化疗治疗局部晚期鼻咽癌[J]. 肿瘤防治研究, 2002, 29(04): 339-340. DOI: 10.3971/j.issn.1000-8578.3313
SONG Qi-bin, HU De-sheng, ZHOU Xiao-yi, et al, . Radiation therapy combined with chemotherapy for locally advanced nasopharyngeal carcinoma[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 339-340. DOI: 10.3971/j.issn.1000-8578.3313
Citation: SONG Qi-bin, HU De-sheng, ZHOU Xiao-yi, et al, . Radiation therapy combined with chemotherapy for locally advanced nasopharyngeal carcinoma[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 339-340. DOI: 10.3971/j.issn.1000-8578.3313

放射治疗配合全身化疗治疗局部晚期鼻咽癌

详细信息
    通讯作者:

    宋启斌

  • 中图分类号: R739.63

Radiation therapy combined with chemotherapy for locally advanced nasopharyngeal carcinoma

More Information
    Corresponding author:

    SONG Qi-bin

  • 摘要: 目的 评价放化结合和单独放疗治疗局部晚期鼻咽癌的疗效和毒副反应。方法 将 4 3例鼻咽癌随机分为放化组和单放组。结果 全组 1、3年生存率分别为 88.4 %和 5 1.2 %, 放化组和单放组的 1年生存率分别为 90 .5 %和 86 .4 % (P >0 .0 5 ), 3年生存率分别为 5 7.1%和 4 5 .5 % (P >0 .0 5 )。放化组的主要毒副反应为恶心、呕吐和白细胞下降, 发生率分别为 90 .5 %和 10 0 %, 均为Ⅰ~Ⅲ度。结论 研究结果显示POB联合化疗合并放射治疗晚期鼻咽癌是可以耐受的, 对改进鼻咽癌的治疗效果仍有待进一步研究

     

    Abstract: Objective To compare the result and side-effect of radiation therapy combined with chemotherapy(CRT) and radiation therapy alone(RT) for locally advanced Nasopharyngeal Carcinoma. Mehods 43 patients with for locally advanced nasopharyngeal carcinoma were radomized into two groups:21 entred in the CRT and 22 in the RT group. Results The survival rates of all the patients at 1 and 3-year were 88.4%,51.2%. The survival rates at 1 and 3-year were 90.5%, 57.1% in the CRT group and86.4%, 45.5% in the RT gro...

     

计量
  • 文章访问数:  1938
  • HTML全文浏览量:  24
  • PDF下载量:  600
  • 被引次数: 0
出版历程
  • 收稿日期:  2002-02-10
  • 修回日期:  2002-07-07
  • 刊出日期:  2002-07-04

目录

    /

    返回文章
    返回
    x 关闭 永久关闭